{
    "organizations": [],
    "uuid": "7d46be765eb0ae3f7d9b942e0e36d7d95a2ed4fc",
    "author": "",
    "url": "https://www.reuters.com/article/brief-rexahn-pharmaceuticals-says-conext/brief-rexahn-pharmaceuticals-says-conext-bt-co-ltd-terminated-some-research-collaboration-agreement-on-rx-0201-clinical-development-dated-feb-6-2003-idUSFWN1PY1OO",
    "ord_in_thread": 0,
    "title": "BRIEF-Rexahn Pharmaceuticals Says Co,Next BT Co Ltd Terminated Some Research Collaboration Agreement On RX-0201 Clinical Development Dated Feb 6, 2003",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Rexahn Pharmaceuticals Inc:\n* REXAHN PHARMACEUTICALS-ON FEB 5,CO,NEXT BT CO. LTD TERMINATED SOME RESEARCH COLLABORATION AGREEMENT ON RX-0201 CLINICAL DEVELOPMENT DATED FEB 6, 2003\n* REXAHN PHARMACEUTICALS - THE TERMINATED AGREEMENT DATED AS OF FEBRUARY 6, 2003, IS BY & BETWEEN CO AND REXGENE BIOTECH\n* REXAHN - IN TERMINATED AGREEMENT, REXGENE AGREED TO ASSIST CO IN RESEARCH,DEVELOPMENT &CLINICAL TRIALS NECESSARY FOR REGISTRATION IN ASIA OF RX-0201\n* REXAHN - TERMINATED AGREEMENT WAS TERMINATED TO ALLOW CO TO TRANSITION TO A NEW DEVELOPMENT STRATEGY FOR RX-0201 & OTHER DRUG CANDIDATES AMONG OTHERS Source text: [ bit.ly/2EtkwFz ] Further company coverage:\n ",
    "published": "2018-02-09T00:09:00.000+02:00",
    "crawled": "2018-02-09T00:22:48.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "rexahn",
        "pharmaceutical",
        "inc",
        "rexahn",
        "feb",
        "co",
        "next",
        "bt",
        "ltd",
        "terminated",
        "research",
        "collaboration",
        "agreement",
        "clinical",
        "development",
        "dated",
        "feb",
        "rexahn",
        "pharmaceutical",
        "terminated",
        "agreement",
        "dated",
        "february",
        "co",
        "rexgene",
        "biotech",
        "rexahn",
        "terminated",
        "agreement",
        "rexgene",
        "agreed",
        "assist",
        "co",
        "research",
        "development",
        "clinical",
        "trial",
        "necessary",
        "registration",
        "asia",
        "rexahn",
        "terminated",
        "agreement",
        "terminated",
        "allow",
        "co",
        "transition",
        "new",
        "development",
        "strategy",
        "drug",
        "candidate",
        "among",
        "others",
        "source",
        "text",
        "company",
        "coverage"
    ]
}